These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24620961)

  • 1. Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor.
    Jangra A; Datusalia AK; Sharma SS
    Neurol Res; 2014 Jul; 36(7):619-26. PubMed ID: 24620961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-PARP pathway.
    Jangra A; Datusalia AK; Khandwe S; Sharma SS
    Pharmacol Biochem Behav; 2013 Dec; 114-115():43-51. PubMed ID: 24201044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
    Negi G; Kumar A; Sharma SS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia.
    Sharma SS; Munusamy S; Thiyagarajan M; Kaul CL
    J Neurosurg; 2004 Oct; 101(4):669-75. PubMed ID: 15481724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-Ribose) Polymerase Inhibition Improves Corneal Epithelial Innervation and Wound Healing in Diabetic Rats.
    Byun YS; Kang B; Yoo YS; Joo CK
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1948-55. PubMed ID: 25711635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
    Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
    J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice.
    Sriram CS; Jangra A; Gurjar SS; Hussain MI; Borah P; Lahkar M; Mohan P; Bezbaruah BK
    Pharmacol Biochem Behav; 2015 Jun; 133():83-91. PubMed ID: 25863272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.
    Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C
    Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of periodontitis in diabetes.
    Adachi K; Miyajima SI; Nakamura N; Miyabe M; Kobayashi Y; Nishikawa T; Suzuki Y; Kikuchi T; Kobayashi S; Saiki T; Mizutani M; Ohno N; Noguchi T; Mitani A; Matsubara T; Naruse K
    J Clin Periodontol; 2017 Oct; 44(10):971-980. PubMed ID: 28570002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
    Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
    Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
    Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
    Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
    Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
    Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.
    Obrosova IG; Mabley JG; Zsengellér Z; Charniauskaya T; Abatan OI; Groves JT; Szabó C
    FASEB J; 2005 Mar; 19(3):401-3. PubMed ID: 15611153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Poly(ADP-Ribose)Polymerase-1 Inhibitor 1,5-Isoquinolinediol Attenuate Diabetes-Induced NADPH Oxidase-Derived Oxidative Stress in Retina.
    Mohammad G; Alrashed SH; Almater AI; Siddiquei MM; Abu El-Asrar AM
    J Ocul Pharmacol Ther; 2018 Sep; 34(7):512-520. PubMed ID: 29912609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N; Sharma G; Singh N; Hanif K
    Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of FeTMPyP: a peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils.
    Dhar A; Kaundal RK; Sharma SS
    Pharmacol Res; 2006 Oct; 54(4):311-6. PubMed ID: 16877004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to fluoride exacerbates the cognitive deficit of diabetic patients living in areas with endemic fluorosis, as well as of rats with type 2 diabetes induced by streptozotocin via a mechanism that may involve excessive activation of the poly(ADP ribose) polymerase-1/P53 pathway.
    Xiang J; Qi XL; Cao K; Ran LY; Zeng XX; Xiao X; Liao W; He WW; Hong W; He Y; Guan ZZ
    Sci Total Environ; 2024 Feb; 912():169512. PubMed ID: 38145685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of poly(ADP-ribose) polymerase inhibitors on some parameters of oxidative stress in blood leukocytes of rats with experimental diabetes].
    Huzyk MM; Diakun KO; Ianits'ka LV; Kuchmerovs'ka TM
    Ukr Biokhim Zh (1999); 2013; 85(1):62-70. PubMed ID: 23534291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
    Obrosova IG; Drel VR; Oltman CL; Mashtalir N; Tibrewala J; Groves JT; Yorek MA
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1645-55. PubMed ID: 17911342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.